Literature DB >> 11199192

Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.

M Sato1, M Westmore, J Clendenon, S Smith, B Hannum, G Q Zeng, R Brommage, C H Turner.   

Abstract

Biomechanical and quantitative computed tomography (QCT) analyses showed beneficial effects of parathyroid hormone (PTH (1-34)) on lumbar vertebrae from ovariectomized monkeys, even after withdrawal of treatment for 6 months. Adult cynomolgus monkeys were randomized, ovariectomized (except for sham ovariectomy controls), and treated subcutaneously with vehicle (OVX) or 5 micrograms/kg per day PTH (1-34) (PTH5) for 18 months. An additional group was treated subcutaneously with 5 micrograms/kg per day PTH (1-34) (PTH5W) for 12 months and then switched to vehicle for the remaining 6 months. Lumbar vertebrae were excised at necropsy, and L5 were serially scanned by QCT, using 70 x 70 x 500 microns voxels. PTH increased volumetric bone mineral density (BMD, mg/cm3) and bone mineral content (BMC, mg) for both PTH5 and PTH5W compared with OVX and Sham without inducing hypermineralization, without stimulating periosteal expansion, and without significant constriction of the neural canal. BMD values for the voxels were then averaged to create nearly isotropic voxels of 490 x 490 x 500 microns. Serial scans were stacked and a triangular surface mesh generated for each bone, using a 'marching cubes' algorithm. A smoothed version of each surface mesh was used to generate a tetrahedral element for three-dimensional finite element modeling. An isotropic Young's modulus for each tetrahedral element was calculated as a function of the original voxel BMDs. Linear elastic stress analysis was then performed for each finite element model in which a distributed load of 100 newtons (N) was applied to the top surface of the centrum, perpendicular to the bottom surface with the bottom surface constrained in the direction of loading. Analysis of the effective strain showed considerable reduction in vertebral strain for both PTH5 and PTH5W, compared with OVX. Compression testing of the adjacent L3 and L4 confirmed that vertebral strength and stiffness for PTH5 and PTH5W were significantly greater than for OVX. Histogram and QCT analyses showed PTH conversion of low-density bone (trabecular bone) into medium-density bone (more and thicker trabeculae) by stimulating bone apposition. PTH withdrawal induced conversion of medium-density into low-density and high-density bone with the latter higher than in OVX. These data show that even transient PTH treatment improves vertebral architecture and bone quality to reduce the likelihood of fracture, and that transient treatment is better than no PTH treatment at all.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11199192     DOI: 10.1007/s001980070047

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  8 in total

Review 1.  Mineral changes in osteoporosis: a review.

Authors:  Dan Faibish; Susan M Ott; Adele L Boskey
Journal:  Clin Orthop Relat Res       Date:  2006-02       Impact factor: 4.176

2.  Parathyroid hormone analogues in the therapy of osteoporosis.

Authors:  Markus Müller; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Combined treatment with parathyroid hormone (1-34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model.

Authors:  Zhou-Shan Tao; Kai-Kai Tu; Zheng-Liang Huang; Qiang Zhou; Tao Sun; Hong-Ming Xu; Yu-Long Zhou; Yang-Xun Lv; Wei Cui; Lei Yang
Journal:  Med Biol Eng Comput       Date:  2015-10-01       Impact factor: 2.602

4.  Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.

Authors:  Yanfei L Ma; Henry U Bryant; Qingqiang Zeng; Allen Schmidt; Webster S S Jee; Masahiko Sato
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 5.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

6.  Effects of combined menaquinone-4 and PTH1-34 treatment on osetogenesis and angiogenesis in calvarial defect in osteopenic rats.

Authors:  She-Ji Weng; Zhong-Jie Xie; Zong-Yi Wu; De-Yi Yan; Jia-Hao Tang; Zi-Jian Shen; Hang Li; Bing-Li Bai; Viraj Boodhun; Xiang Da Eric Dong; Lei Yang
Journal:  Endocrine       Date:  2018-09-22       Impact factor: 3.633

7.  Effect of Bone Mineral Density on Rotator Cuff Tear: An Osteoporotic Rabbit Model.

Authors:  Xiaobin Chen; Hugo Giambini; Ephraim Ben-Abraham; Kai-Nan An; Ahmad Nassr; Chunfeng Zhao
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

8.  Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.

Authors:  N Doyle; A Varela; S Haile; R Guldberg; P J Kostenuik; M S Ominsky; S Y Smith; G Hattersley
Journal:  Osteoporos Int       Date:  2017-12-19       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.